The combination of antigen (PPI) with the three immune response modifiers (TGFβ1, IL-10, and IL-2) is intended to induce antigen-specific Treg accumulating in the pancreas, and to preserve beta cell function in type 1 diabetes (T1D). Here, IL2 is linked to type 1 diabetes mellitus.